MDPI and ACS Style
Arafa, F.M.; Said, H.; Osman, D.; Rezki, N.; Aouad, M.R.; Hagar, M.; Osman, M.; Elwakil, B.H.; Jaremko, M.; Tolba, M.M.
Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study. Trop. Med. Infect. Dis. 2023, 8, 401.
https://doi.org/10.3390/tropicalmed8080401
AMA Style
Arafa FM, Said H, Osman D, Rezki N, Aouad MR, Hagar M, Osman M, Elwakil BH, Jaremko M, Tolba MM.
Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study. Tropical Medicine and Infectious Disease. 2023; 8(8):401.
https://doi.org/10.3390/tropicalmed8080401
Chicago/Turabian Style
Arafa, Fadwa M., Heba Said, Doaa Osman, Nadjet Rezki, Mohamed R. Aouad, Mohamed Hagar, Mervat Osman, Bassma H. Elwakil, Mariusz Jaremko, and Mona Mohamed Tolba.
2023. "Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study" Tropical Medicine and Infectious Disease 8, no. 8: 401.
https://doi.org/10.3390/tropicalmed8080401